- Home
- ITOS vs CADL Comparison
ITOS vs CADL Comparison
Compare ITOS & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ITOS
- CADL
- Stock Information
- Founded
- ITOS 2011
- CADL 1999
- Country
- ITOS United States
- CADL United States
- Employees
- ITOS N/A
- CADL N/A
- Industry
- ITOS Biotechnology: Biological Products (No Diagnostic Substances)
- CADL Biotechnology: Pharmaceutical Preparations
- Sector
- ITOS Health Care
- CADL Health Care
- Exchange
- ITOS Nasdaq
- CADL Nasdaq
- Market Cap
- ITOS 270.7M
- CADL 306.4M
- IPO Year
- ITOS 2020
- CADL 2021
- Fundamental
- Price
- ITOS $7.19
- CADL $7.94
- Analyst Decision
- ITOS Strong Buy
- CADL Strong Buy
- Analyst Count
- ITOS 3
- CADL 4
- Target Price
- ITOS $26.00
- CADL $21.00
- AVG Volume (30 Days)
- ITOS 334.2K
- CADL 1.4M
- Earning Date
- ITOS 03-05-2025
- CADL 03-27-2025
- Dividend Yield
- ITOS N/A
- CADL N/A
- EPS Growth
- ITOS N/A
- CADL N/A
- EPS
- ITOS N/A
- CADL N/A
- Revenue
- ITOS $35,000,000.00
- CADL N/A
- Revenue This Year
- ITOS N/A
- CADL N/A
- Revenue Next Year
- ITOS $121.70
- CADL N/A
- P/E Ratio
- ITOS N/A
- CADL N/A
- Revenue Growth
- ITOS 177.89
- CADL N/A
- 52 Week Low
- ITOS $6.67
- CADL $1.34
- 52 Week High
- ITOS $18.75
- CADL $14.60
- Technical
- Relative Strength Index (RSI)
- ITOS 48.18
- CADL 45.61
- Support Level
- ITOS $6.73
- CADL $7.65
- Resistance Level
- ITOS $7.32
- CADL $8.31
- Average True Range (ATR)
- ITOS 0.38
- CADL 0.95
- MACD
- ITOS 0.03
- CADL -0.17
- Stochastic Oscillator
- ITOS 53.06
- CADL 13.56
About ITOS iTeos Therapeutics Inc.
ITeos Therapeutics Inc is a biopharmaceutical company. It designs novel product candidates with optimized pharmacologic properties to improve clinical outcomes by restoring the immune response against cancer. The company's product candidates include EOS-850 which is an Adenosine A2A receptor-specific antagonist, EOS-448 which is an ADCC-enabled, anti-TIGIT immune checkpoint blocking antibody among other drug candidates.
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.